Replies to post #429924 on NorthWest Biotherapeutics Inc (NWBO)

[iclight]

It needs to be discussed every time someone brings up her quotes and the company refuses to release the data.

She made that quote well before the majority of the control arm would have crossed over.

All your points represent a poorly designed trial with no chance of approval. Thus the endpoint change.